Acura Pharmaceuticals, Inc
ACURDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000786947
Acura Pharmaceuticals, Inc was delisted in 2025; its insiders filed their last Form 4 on Jan 15, 2026; no institution reported holding it in 13F filings for Q4 2024; no superinvestor held it.
Holders of 5% or more of ACUR
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Acura Pharmaceuticals, Inc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Acura Pharmaceuticals, Inc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Acura Pharmaceuticals, Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 2022 | Essex Woodlands Health Ventures Fund V LP | 13D/AOld format | – | – | – | SEC |
| Jun 28, 2021 | Schutte John | 13D/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Acura Pharmaceuticals, Inc shares.
No Form 144 notices for Acura Pharmaceuticals, Inc are on file.